Business Description
Cyduct Diagnostics Inc
NAICS : 325413
SIC : 3844
ISIN : US23256Q1058
Compare
Compare
Traded in other countries / regions
CYDX.USA Description
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 94.56 | |||||
9-Day RSI | 57.92 | |||||
14-Day RSI | 32.33 | |||||
3-1 Month Momentum % | -35.62 | |||||
6-1 Month Momentum % | 98.42 | |||||
12-1 Month Momentum % | 59.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CYDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyduct Diagnostics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | 1.9283 | ||
| 3-Year Sharpe Ratio | 0.66 | ||
| 3-Year Sortino Ratio | 2.36 | ||
| Volatility % | 303.46 | ||
| 14-Day RSI | 32.33 | ||
| 14-Day ATR ($) | 0.002417 | ||
| 20-Day SMA ($) | 0.4098 | ||
| 12-1 Month Momentum % | 59.86 | ||
| 52-Week Range ($) | 0.2 - 2.9 | ||
| Shares Outstanding (Mil) | 5.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cyduct Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cyduct Diagnostics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.004:1 Stock Split | 2020-12-01 | 0.93 (+0.00%) | ||
| 0.000667:1 Stock Split | 2015-09-24 | 37.48 (+0.00%) | ||
| 0.0005:1 Stock Split | 2010-11-24 | 307,692.31 (-33.33%) | ||
| 0.0002:1 Stock Split | 2008-05-29 | 115,384,615.38 (+200.00%) | ||
| 0.01:1 Stock Split | 2007-01-16 | -- |
Show
Entries
Cyduct Diagnostics Inc Frequently Asked Questions
What is Cyduct Diagnostics Inc(CYDX)'s stock price today?
The current price of CYDX is $0.42. The 52 week high of CYDX is $2.90 and 52 week low is $0.20.
When is next earnings date of Cyduct Diagnostics Inc(CYDX)?
The next earnings date of Cyduct Diagnostics Inc(CYDX) is .
Does Cyduct Diagnostics Inc(CYDX) pay dividends? If so, how much?
Cyduct Diagnostics Inc(CYDX) does not pay dividend.
Guru Commentaries on OTCPK:CYDX
No articles.
Press Release
Articles on Cyduct Diagnostics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers